ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 722,00
0,68%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Calmare Therapeutics Inc (CE) (CTTC)

  7. Calmare Therapeutics Inc (CE) (CTTC) Actualités

CTTC

Calmare Therapeutics (CE) (CTTC)

Calmare Therapeutics Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:CTTC
DateHeureSourceTitreSymboleSociété
09/06/202023h27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
11/02/202021h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
03/07/201800h28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
03/07/201800h14Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
06/03/201819h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CTTCCalmare Therapeutics Inc (CE)
20/02/201815h47Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
13/02/201819h43Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CTTCCalmare Therapeutics Inc (CE)
16/01/201823h16Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
12/01/201812h06Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
02/01/201812h05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
05/12/201717h00Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
04/12/201721h06Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
22/11/201722h44Edgar (US Regulatory)Proxy Statements Not Involving Contested Solicitations (preliminary) (pren14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
15/11/201723h16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CTTCCalmare Therapeutics Inc (CE)
21/09/201716h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
21/07/201723h00Edgar (US Regulatory)Annual Report (10-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
30/06/201723h06Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:CTTCCalmare Therapeutics Inc (CE)
31/03/201722h42Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CTTCCalmare Therapeutics Inc (CE)
29/12/201622h09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CTTCCalmare Therapeutics Inc (CE)
25/10/201623h32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CTTCCalmare Therapeutics Inc (CE)
09/12/201412h01Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:CTTCCalmare Therapeutics Inc (CE)
14/11/201412h02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:CTTCCalmare Therapeutics Inc (CE)
03/07/201421h18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CTTCCalmare Therapeutics Inc (CE)
30/04/201423h30Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CTTCCalmare Therapeutics Inc (CE)
01/04/201422h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:CTTCCalmare Therapeutics Inc (CE)
01/04/201422h13Edgar (US Regulatory)(40-17F1)USOTC:CTTCCalmare Therapeutics Inc (CE)
06/12/201321h00ZacksSouFun Prices Senior Notes - Analyst BlogUSOTC:CTTCCalmare Therapeutics Inc (CE)
05/11/201319h19MarketwiredCalmare Pain Relief Solutions Adds New Calmare(R) Pain Therapy ClinicsUSOTC:CTTCCalmare Therapeutics Inc (CE)
15/10/201318h54OTC MarketsCompetitive Tech Selected To Provide Pain Care Training To U.S. Military PersonnelUSOTC:CTTCCalmare Therapeutics Inc (CE)
04/10/201315h00OTC MarketsCompetitive Tech Appoints Conrad F. Mir as New President, CEO & Member of the BoardUSOTC:CTTCCalmare Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:CTTC

Dernières Valeurs Consultées

AMEX
EAPR
Innovator Emerging Marke...
EU
I292T
I292T
TG
32Z
South32
AMEX
ISL
CRTO
DOGEUSD
Dogecoin
TSXV
NEE.WT
Northern Vertex Mining
COIN
THOLETH
Tholos
EU
1435T
1435T
ASX
FTTND
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés